REMODULIN
Google image searchProduct monograph
Active ingredient
treprostinil (treprostinil sodium), 2.5 MG/ML
DIN: 02246553
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS
Schedule: Prescription
Company: UNITED THERAPEUTICS CORPORATION
Date: 07-OCT-2005
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AC — Platelet aggregation inhibitors excl. heparin (ATC, ATC/DDD)
- B01AC21 — TREPROSTINIL (ATC/DDD)
Reference brand drug: Remodulin
Pharmaceutical standard: MFR
